Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retroperitoneal sarcomas.

F C Eilber1, K S Eilber, F R Eilber

  • 1Department of Surgery, Division of Surgical Oncology, 54-140 CHS, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA, 90095-1782, USA.

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conservative management of a grade 4 renal laceration in a child.

Reviews in urology·2006
Same author

Obstructive uropathy secondary to ureteroinguinal herniation.

Reviews in urology·2006
Same author

Polyarteritis nodosa presenting as hematuria and a testicular mass.

The Journal of urology·2001
Same author

Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

Soft tissue echinococcosis: a report of two cases and review of the literature.

Clinical orthopaedics and related research·2001
Same author

Large, deep, high-grade extremity sarcomas: treating tumors of the flexor fossae.

Surgical oncology·2000
Same journal

Interaction between Regulated Cell Death Pathways and Core Cellular Processes: Unraveling the Molecular Mechanisms of Cardiotoxicity of Antitumor Drugs.

Current treatment options in oncology·2026
Same journal

Advances in Immunotherapy for Breast Cancer: Up-to-date Strategies of Immune Checkpoint Inhibitors and Therapeutic Vaccines.

Current treatment options in oncology·2026
Same journal

Recent Advances in Neoadjuvant Treatment of Anaplastic Thyroid Carcinoma: A Narrative Review.

Current treatment options in oncology·2026
Same journal

The Immunological Landscape of the Tumor Microenvironment: Implications for Immunotherapy of Unresectable and Metastatic Soft Tissue Sarcomas.

Current treatment options in oncology·2026
Same journal

Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer.

Current treatment options in oncology·2026
Same journal

Emerging Applications of CAR-T Cell Therapy in Overcoming Resistance and Expanding Targets in Hematologic Malignancies: Insights from Recent Research.

Current treatment options in oncology·2026
See all related articles

Management of retroperitoneal tumors involves imaging and biopsy for diagnosis. Surgical resection is the primary treatment for sarcomas, with adjuvant therapies showing no proven benefit.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Radiology

Background:

  • Retroperitoneal tumors require a systematic diagnostic and management approach.
  • Accurate histologic diagnosis is crucial for effective treatment planning.

Purpose of the Study:

  • To outline the diagnostic and therapeutic strategies for retroperitoneal tumors, with a focus on sarcomas.
  • To emphasize the role of multidisciplinary management and surgical resection.

Main Methods:

  • Initial assessment includes history, physical examination, and computed tomography (CT) for imaging and tissue acquisition.
  • CT-guided core biopsy is utilized for histologic diagnosis.
  • Staging for sarcomas involves chest radiography and liver imaging (CT or MRI).

Related Experiment Videos

Main Results:

  • Surgical resection, often en bloc with adjacent organs, remains the cornerstone of treatment for retroperitoneal sarcomas.
  • Chemotherapy may be beneficial in a neoadjuvant setting for specific chemosensitive subtypes.
  • Postoperative adjuvant therapy (chemotherapy or radiation) has not demonstrated additional benefit.

Conclusions:

  • Treatment outcomes are significantly influenced by tumor stage, grade, size, and surgical resection margins.
  • Multidisciplinary team management is essential for optimal treatment planning.
  • Regular follow-up imaging and resection of recurrences are important components of long-term care.